Cargando…

Isolated Central Adrenal Insufficiency Due to Nivolumab: A Case Report

Background: Immune checkpoint inhibitors are immunomodulatory antibodies directed against programmed cell death 1 (PD-1), Nivolumab, or cytotoxic T-lymphocyte antigen-4 (CTLA-4) Ipilimumab. They have improved outcomes in patients with advanced cancers including renal cell carcinoma, non-small cell l...

Descripción completa

Detalles Bibliográficos
Autores principales: Rjoob, Hani, Khan, Tayyab S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265911/
http://dx.doi.org/10.1210/jendso/bvab048.1204

Ejemplares similares